Wedbush Initiates Disc Medicine at Outperform With $30 Price Target - Marketscreener.com

1 year ago 46

Delayed Nasdaq  -  03:59 2023-01-03 p.m. EST 17.95 USD   -9.75%

01/04/2023 | 07:26am EST MT Newswires 2023 All quality about DISC MEDICINE, INC. 07:26a Wedbush Initiates Disc Medicine astatine Outperform With $30 Price Target MT 2022 Disc Medicine, Inc.(NasdaqGM:IRON) added to NASDAQ Composit.. CI Analyst Recommendations on DISC MEDICINE, INC. 07:26a Wedbush Initiates Disc Medicine astatine Outperform With $30 Price Target MT		Financials (USD) Sales 2022 - - - Net income 2022 -91,9 M - - Net Debt 2022 - - - P/E ratio 2022 -3,40x Yield 2022 - Capitalization 304 M 304 M - Capi. / Sales 2022 - Capi. / Sales 2023 - Nbr of Employees - Free-Float 2,27% Chart DISC MEDICINE, INC. Duration : Period : Income Statement Evolution Sector and Competitors 1st jan. Capi. (M$) DISC MEDICINE, INC. -9.75% 304 MODERNA, INC. 0.00% 68 764 IQVIA HOLDINGS INC. -0.50% 37 865 LONZA GROUP AG 1.77% 36 500 ALNYLAM PHARMACEUTICALS, INC. 0.00% 28 738 SEAGEN INC. 0.15% 23 895

1. Homepage
2. Health
3. Wedbush Initiates Disc Medicine at Outperform With $30 Price Target - Marketscreener.com